Related Experiment Video
Updated: Aug 4, 2026
09:27
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
Published on: January 5, 2016
Peroxidative aggregation of alpha-synuclein requires tyrosines
1Department of Chemistry, University of North Carolina, Chapel Hill, NC 27599, USA.
Protein Science : a Publication of the Protein Society
|October 2, 2004
Summary
Oxidative stress causes alpha-synuclein aggregation in Parkinson's disease. This study identifies tyrosine amino acids as critical for this aggregation process, revealing a key chemical step.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Parkinson's disease is characterized by alpha-synuclein protein aggregates in neurons.
- Oxidative damage is linked to Parkinson's disease occurrence.
- Peroxidative chemistry is known to induce alpha-synuclein aggregation in vitro, but specific amino acids involved were unidentified.
Purpose of the Study:
- To identify the specific amino acid residues of alpha-synuclein crucial for aggregation under oxidative stress.
- To elucidate the chemical basis of alpha-synuclein aggregation in the context of Parkinson's disease.
Main Methods:
- Induction of oxidative stress using human cytochrome c and hydrogen peroxide (H2O2).
- In vitro studies analyzing alpha-synuclein aggregation.
- Chemical analysis to pinpoint involved amino acid types.
Main Results:
- Tyrosine residues of alpha-synuclein were identified as essential for aggregation.
- Oxidative stress specifically targets tyrosines, initiating the aggregation cascade.
- This research reveals the chemical mechanism underlying a critical step in alpha-synuclein aggregation.
Conclusions:
- Tyrosine modification is a key event in alpha-synuclein aggregation driven by oxidative stress.
- Understanding this chemical pathway offers insights into Parkinson's disease pathogenesis.
- Targeting tyrosine-mediated aggregation could be a potential therapeutic strategy.
More Related Videos
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:26Protein Modifications in the RER
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...